4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prenatal thoraco-amniotic chest drain insertion to manage a case of fetal hydrops secondary to FOXC2

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lymphoedema-distichiasis is an inherited autosomal dominant disorder of the lymphatic system. Rarely, it is associated with fetal hydrops; the risk and severity of which increases with successive generations. The causative gene is a member of the forkhead transcription factor family ( FOXC2). We describe a fetus presenting with early-onset, rapidly progressing body wall oedema, bilateral pleural effusions and a pericardial effusion in a mother with known FOXC2 mutation. First trimester chorionic villus sampling confirmed FOXC2 mutation in the fetus when there was only a large nuchal translucency. As the phenotype progressed, the couple consented to in utero ultrasound-guided insertion of sequential bilateral pleuro-amniotic chest drains (at 23 weeks) which successfully drained the pleural effusions. The fetus was delivered at 39 weeks gestation by elective caesarean section in good condition. The shunts were removed postnatally, and the baby was discharged after 7 days. This is the first case described of a fetus with severe early-onset fetal hydrops secondary to FOXC2 mutation successfully treated by the prenatal insertion of bilateral pleuro-amniotic shunts.

          Related collections

          Author and article information

          Journal
          BMJ Case Rep
          BMJ Case Rep
          casereports
          bmjcasereports
          BMJ Case Reports
          BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
          1757-790X
          2018
          4 June 2018
          : 2018
          : bcr2017223902
          Affiliations
          [1 ] departmentObstetrics and Gynaecology , Burton Hospitals NHS Foundation Trust , Staffordshire, UK
          [2 ] departmentFetal Medicine Centre , Birmingham Women’s and Children’s NHS Foundation Trust , Birmingham, UK
          [3 ] departmentInstitute of Metabolism and System Research , University of Birmingham , Edgbaston, UK
          [4 ] departmentWest Midlands Genetic Centre , Birmingham Women’s & Children’s Foundation Trust , Birmingham, UK
          Author notes
          [Correspondence to ] Dr Nidhi Gulati, nidhigulati@ 123456nhs.net
          Article
          PMC5990056 PMC5990056 5990056 bcr-2017-223902
          10.1136/bcr-2017-223902
          5990056
          29866673
          c71d5f66-99fb-403e-9d79-041fa872a707
          © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
          History
          : 25 April 2018
          Categories
          Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
          1522
          276
          Case Report

          pregnancy,materno-fetal medicine,obstetrics and gynaecology,congenital disorders

          Comments

          Comment on this article